Found 17 matching trials
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
PHASE2The purpose of this study is to find out whether combining a shorter than s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
GP Extended Action Triptorelin
PHASE4The purpose of this study is to demonstrate that treatment with a 6-monthly...
Location
The Crouch Oak Family Practice
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
PHASE2To assess the safety of treating men with oligometastatic prostate cancer w...
Location
Johns Hopkins Sibley Memorial Hospital
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy
PHASE2The purpose of this research study is to assess the efficacy of antiangioge...
Location
Johns Hopkins University
Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
PHASE2The addition of abiraterone acetate to standard treatment of radiotherapy a...
Location
Durham Regional Hospital
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
PHASE2The primary objective is to determine the safety and activity of combined h...
Status
Active Not Recruiting
Location
Columbia University Irving Medical Center
Evaluate Recovery of Testosterone for Patients Using Eligard
PHASE4The purpose of this study is to determine if testosterone will recover to 9...
Location
Multiple Locations
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
PHASE2This is a phase II randomized, open-label study comparing salvage radiother...
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
PHASE2RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, ...
Location
Beebe Medical Center
Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
PHASE2Prostate cancer is the second most common cancer among Canadian men of whic...
Location
McGill University Health Centre- Cedars Cancer Centre